A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation
Immunotherapy has revolutionized the treatment landscape for many cancers, including some B- cell lymphomas. Immune checkpoint blockade, CAR-T cells and bispecific antibodies have shown promise for the treatment of Richter Transformation (RT) but have …